Furthermore, the C-X-C chemokine receptor type 4 (CXCR-4) was found to be upregulated on breast cancer CTCs, suggesting a potential role in regulating immune cell recruitment and function in the tumor microenvironment during treatment (38). Here, CXCR4 is linked to breast carcinoma.